Results 1 to 10 of about 258,277 (308)

Allergen immunotherapy: past, present and future

open access: yesNature Reviews Immunology, 2022
Durham and Shamji review the history and future of allergen immunotherapy for established IgE-mediated hypersensitivity to common allergens. They describe the mechanisms of immunotherapy-induced tolerance and the new strategies being explored to achieve ...
Stephen Durham
exaly   +2 more sources

The role of allergen‐specific IgE, IgG and IgA in allergic disease

open access: yesAllergy: European Journal of Allergy and Clinical Immunology, 2021
Immunoglobulin E (IgE)‐mediated allergy is the most common hypersensitivity disease affecting more than 30% of the population. Exposure to even minute quantities of allergens can lead to the production of IgE antibodies in atopic individuals.
Mohamed Shamji   +2 more
exaly   +2 more sources

Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses

open access: yesFrontiers in Immunology, 2019
Immunoglobulin E (IgE)-associated allergy is the most common immunologically-mediated hypersensensitivity disease. It is based on the production of IgE antibodies and T cell responses against per se innocuous antigens (i.e., allergens) and subsequent ...
Julia Eckl-Dorna   +9 more
doaj   +2 more sources

Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement

open access: yesNature Communications, 2018
Acute allergic symptoms are caused by allergen-induced crosslinking of allergen-specific immunoglobulin E (IgE) bound to Fc-epsilon receptors on effector cells.
Andrew J Murphy
exaly   +2 more sources

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis

open access: yesAllergy: European Journal of Allergy and Clinical Immunology, 2018
Graham C Roberts, Oliver Pfaar
exaly   +2 more sources

Allergen immunotherapy for IgE‐mediated food allergy: a systematic review and meta‐analysis

open access: yesAllergy: European Journal of Allergy and Clinical Immunology, 2017
Sangeeta Dhami   +2 more
exaly   +2 more sources

Allergen immunotherapy for allergic asthma: A systematic review and meta‐analysis

open access: yesAllergy: European Journal of Allergy and Clinical Immunology, 2017
Sangeeta Dhami   +2 more
exaly   +2 more sources

Comparison of the Immune Responses to Different Formulations of BC02-Adjuvanted HPV Types 16 and 18 Bivalent Vaccines in Mice

open access: yesVaccines, 2023
To achieve maximum efficacy, vaccines, such as subunit, recombinant, and conjugate vaccines, necessitate the incorporation of immunostimulators/adjuvants.
Junli Li   +7 more
doaj   +1 more source

Novel BC02 Compound Adjuvant Enhances Adaptive and Innate Immunity Induced by Recombinant Glycoprotein E of Varicella-Zoster Virus

open access: yesVaccines, 2022
Both adaptive and innate immunity responses are necessary for the efficient elimination of different pathogens. However, the magnitude, quality and desired type of immune response specific to the co-administered antigen is largely determined by adjuvants.
Junli Li   +6 more
doaj   +1 more source

Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycoprotein E in Mice by Addition of a Novel BC02 Compound Adjuvant

open access: yesVaccines, 2022
Herpes zoster (HZ) is one of two distinct syndromes caused by Varicella-zoster virus (VZV). A primary infection with VZV causes varicella in susceptible young children.
Junli Li   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy